Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Assembly Biosciences (ASMB) over the last 9 years, with Q3 2025 value amounting to 0.41%.

  • Assembly Biosciences' Return on Capital Employed rose 3000.0% to 0.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.41%, marking a year-over-year increase of 3000.0%. This contributed to the annual value of 0.57% for FY2024, which is 2400.0% up from last year.
  • Assembly Biosciences' Return on Capital Employed amounted to 0.41% in Q3 2025, which was up 3000.0% from 1.02% recorded in Q2 2025.
  • Assembly Biosciences' 5-year Return on Capital Employed high stood at 0.24% for Q1 2021, and its period low was 2.21% during Q3 2023.
  • Over the past 4 years, Assembly Biosciences' median Return on Capital Employed value was 0.7% (recorded in 2024), while the average stood at 0.89%.
  • As far as peak fluctuations go, Assembly Biosciences' Return on Capital Employed tumbled by -4100bps in 2021, and later skyrocketed by 15100bps in 2024.
  • Over the past 4 years, Assembly Biosciences' Return on Capital Employed (Quarter) stood at 0.65% in 2021, then crashed by -81bps to 1.18% in 2023, then soared by 38bps to 0.73% in 2024, then soared by 45bps to 0.41% in 2025.
  • Its Return on Capital Employed was 0.41% in Q3 2025, compared to 1.02% in Q2 2025 and 0.71% in Q1 2025.